North Brunswick, NJ (June 13, 2008). Sophion Bioscience, a leader in the automated patch clamp field, announces the hiring of Nick Byrne, Ph.D. as Director of Technical Services, North America. Dr. Byrne is based on the West Coast of the US and focuses efforts on supporting a growing number of QPatch customers in that region.
Dr. Byrne has an extensive background as an electrophysiologist, engineer and inventor. He received his Ph.D. in Pharmacology from the University of Glasgow (UK). In the late 1990’s, Dr. Byrne was a leading force in the development of one of the world’s first automated patch clamp systems, the AutoPatch, by CeNeS (UK). Since then, he has played a primary role in the development of automated patch clamp and other high throughput systems at Axon Instruments, MDC and MDS Analytical Technologies.
“I was delighted to get the opportunity to join the innovative team at Sophion who have taken the lead in the development of automated patch clamp systems” says Dr. Byrne. “I am also very excited about this opportunity to lead the technical services group at Sophion Bioscience, Inc. We at Sophion believe that customer service is a critical aspect of the automated patch clamp business and are committed to providing the best support for our customers.”
Dr. Chris Mathes, Vice-president and General Manager of Sophion Bioscience, Inc., is very satisfied with the reception of the QPatch by customers and clients in North America. “Now that we have a strong presence on the West Coast, Sophion really needed someone located in that region,” says Dr. Mathes. “With his reputation as an innovator, Dr. Byrne also fits perfectly with the Sophion team.”
About Sophion Bioscience
Sophion Bioscience was founded in July 2000, emerging from a successful research and development program at NeuroSearch. Sophion’s sole focus is to provide advanced products and integrated solutions for automated patch clamping.
The QPatch automated patch clamp system provides high-quality patch clamp data on a truly industrial basis. The QPatch 16 was the first system in its class with integrated cell preparation and QPlate exchange facilities enabling several hours of unattended operation. The unique flow channel system implemented in the consumable QPlates enables fast liquid exchange around the cell and provides the option to test multiple compounds or concentrations on the same cell. The QPatch HT, with 48 independent recording channels, stands alone in respect to the highest throughput for a gigaseal automated patch clamp system. Moreover, the QPatch 16 can be upgraded to the QPatch HT, allowing customers to expand as their ion channel programs grow.
For more information about QPatch and/or Sophion, please see www.sophion.com or contact Torsten Freltoft, Ph.D., CEO: tof@sophion.dk or Chris Mathes, Ph.D., Vice-president, Sophion Bioscience Inc., e-mail: cma@sophion.com or telephone 732-745-0221
page top
Join our mailinglist